The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SGRY | -26.14% | +1.47% | +0.29% | +24% |
| S&P | +16.9% | +95.99% | +14.39% | +248% |
Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $826.20M | 8.4% |
| Gross Profit | $155.30M | 7.5% |
| Gross Margin | 18.80% | -0.2% |
| Market Cap | $2.85B | -5.8% |
| Market Cap / Employee | $0.19M | 0.0% |
| Employees | 15K | 11.1% |
| Net Income | $44.90M | 58.1% |
| EBITDA | $159.50M | 14.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $250.10M | 17.1% |
| Accounts Receivable | $563.10M | 7.6% |
| Inventory | 87.3 | 7.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $3.73B | 13.1% |
| Short Term Debt | $149.60M | 13.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -2.34% | -1.9% |
| Return On Invested Capital | -1.92% | -0.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $57.90M | 3.6% |
| Operating Free Cash Flow | $81.30M | -1.8% |
| Metric | Q1 2024 | YoY Change | |||
|---|---|---|---|---|---|
| Price to Earnings | 9943.33 | - | |||
| Price to Book | 2.16 | 1.42 | 1.69 | 1.64 | 6.53% |
| Price to Sales | 1.36 | 0.86 | 0.95 | 0.87 | -16.04% |
| Price to Tangible Book Value | -1.38 | -0.91 | -0.91 | -0.83 | -31.77% |
| Price to Free Cash Flow TTM | 24.89 | 12.74 | 17.35 | 16.10 | 9.52% |
| Enterprise Value to EBITDA | 60.80 | 40.24 | 67.41 | 51.92 | -8.50% |
| Free Cash Flow Yield | 4.0% | 7.8% | 5.8% | 6.2% | -8.70% |
| Return on Equity | -3.1% | -8.9% | -10.4% | -9.7% | 472.65% |
| Total Debt | $3.52B | $3.70B | $3.86B | $3.88B | 13.11% |
SGRY earnings call for the period ending June 30, 2022.
SGRY earnings call for the period ending March 31, 2022.
SGRY earnings call for the period ending December 31, 2021.
SGRY earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
